David Kirn Sells 4D Molecular Therapeutics Stock

David Kirn, President and CEO of 4D Molecular Therapeutics, Inc. (FDMT), sold a total of 58,333 shares of common stock on October 5, 2026. The sales were executed as part of a 10b5-1 trading plan. The first transaction involved 58,061 shares sold at a weighted average price of $12.9215. The second transaction involved 272 shares sold at a weighted average price of $13.6104. Following these transactions, Mr. Kirn directly owns 709,153 shares of common stock.